Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07476144Phase 1Active, not recruiting
Phase 1, randomised trial of nicotine inhaler (12 arms). Primary endpoints: Investigational Product nicotine pharmacokinetics and abuse liability and Characterize nicotine PK Parameters. Started Jan 2026; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07476144.